{"id":"https://openalex.org/W4361945236","doi":"https://doi.org/10.1158/1078-0432.c.6523178","title":"Data from Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B-cell Lymphoma","display_name":"Data from Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B-cell Lymphoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361945236","doi":"https://doi.org/10.1158/1078-0432.c.6523178"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6523178","doi":"https://doi.org/10.1158/1078-0432.c.6523178","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523178","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6523178","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009917980","display_name":"Sally E. Trabucco","orcid":"https://orcid.org/0000-0002-8836-1542","observed_orcids":["https://orcid.org/0000-0002-8836-1542"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sally E. Trabucco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057150258","display_name":"Rachel M. Gerstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel M. Gerstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064091455","display_name":"Andrew M. Evens","orcid":"https://orcid.org/0000-0002-6900-1824","observed_orcids":["https://orcid.org/0000-0002-6900-1824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew M. Evens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110274677","display_name":"James E. Bradner","orcid":"https://orcid.org/0000-0002-2718-4415","observed_orcids":["https://orcid.org/0000-0002-2718-4415","https://orcid.org/0000-0003-1422-5318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James E. Bradner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036394378","display_name":"Leonard D. Shultz","orcid":"https://orcid.org/0000-0002-4868-1031","observed_orcids":["https://orcid.org/0000-0002-4868-1031"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonard D. Shultz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022634163","display_name":"Dale L. Greiner","orcid":"https://orcid.org/0000-0002-5923-339X","observed_orcids":["https://orcid.org/0000-0002-5923-339X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dale L. Greiner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100430269","display_name":"Hong Zhang","orcid":"https://orcid.org/0000-0002-1844-799X","observed_orcids":["https://orcid.org/0000-0002-1844-799X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.1071000024676323,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bromodomain-proteins","display_name":"bromodomain proteins","score":0.7689999938011169},{"id":"https://openalex.org/keywords/bet-proteins","display_name":"BET proteins","score":0.722000002861023},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.996999979019165},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.8999999761581421},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.8600000143051147},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.8939999938011169},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.9440000057220459},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7599999904632568},{"id":"https://openalex.org/keywords/myc-amplification","display_name":"MYC amplification","score":0.6480000019073486},{"id":"https://openalex.org/keywords/myc-translocation","display_name":"MYC translocation","score":0.9079999923706055}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.7353934049606323},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.6733458638191223},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6368300914764404},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6288740634918213},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.467830091714859},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.449216365814209},{"id":"https://openalex.org/C2780862049","wikidata":"https://www.wikidata.org/wiki/Q25326844","display_name":"BET inhibitor","level":5,"score":0.4460964500904083},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4455467462539673},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42594146728515625},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4253940284252167},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41614770889282227},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3415372371673584},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.336037814617157},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2580466866493225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24811089038848877},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.24495220184326172},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.15616756677627563},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11688846349716187},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06505775451660156},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0650542676448822},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6523178","doi":"https://doi.org/10.1158/1078-0432.c.6523178","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523178","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6523178.v1","doi":"https://doi.org/10.1158/1078-0432.c.6523178.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523178.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6523178","doi":"https://doi.org/10.1158/1078-0432.c.6523178","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523178","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2056936324","https://openalex.org/W255626605","https://openalex.org/W2341820900","https://openalex.org/W6983483615","https://openalex.org/W4292682665","https://openalex.org/W2588240037","https://openalex.org/W4361911306","https://openalex.org/W2566037995","https://openalex.org/W143166624","https://openalex.org/W2750819425"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Approximately":[2],"50%":[3],"of":[4,52,64,71,94,101,111,132,141,149,173,180,197,206,215,219,231],"patients":[5,72],"with":[6,19,73],"diffuse":[7],"large":[8],"B-cell":[9],"lymphoma":[10],"(DLBCL)":[11],"enter":[12],"long-term":[13],"remission":[14],"after":[15],"standard":[16],"chemotherapy.":[17],"Patients":[18],"DLBCL":[20,57,83,112,134,162,198],"who":[21],"do":[22],"not":[23],"respond":[24],"to":[25,36],"chemotherapy":[26],"have":[27,48],"few":[28],"treatment":[29,160,182,193,230],"options.":[30],"There":[31],"remains":[32],"a":[33,79,137,146,178],"critical":[34],"need":[35],"identify":[37],"effective":[38],"and":[39,58,67,97,116,203,245],"targeted":[40],"therapeutics":[41],"for":[42,82],"DLBCL.":[43,152,232],"Experimental":[44],"Design:":[45],"Recent":[46],"studies":[47],"highlighted":[49],"the":[50,59,95,184,216,229],"incidence":[51],"increased":[53],"c-MYC":[54,65,77,90,174],"protein":[55,66],"in":[56,114,119,136,151,161,201,228],"correlation":[60],"between":[61],"high":[62],"levels":[63],"poor":[68],"survival":[69,205],"prognosis":[70],"DLBCL,":[74],"suggesting":[75,145],"that":[76,124,213],"is":[78],"compelling":[80],"target":[81],"therapy.":[84],"The":[85,153,171],"small":[86],"molecule":[87],"JQ1":[88,107,125,150,159,181,192,223],"suppresses":[89],"expression":[91,172],"through":[92],"inhibition":[93,214],"bromodomain":[96,102,220],"extra-terminal":[98],"(BET)":[99],"family":[100,218],"proteins.":[103],"We":[104,122],"investigated":[105],"whether":[106],"can":[108],"inhibit":[109],"proliferation":[110,131],"cells":[113,135,163,199],"culture":[115],"xenograft":[117],"models":[118],"vivo.":[120],"Results:":[121],"show":[123],"at":[126],"nanomolar":[127],"concentrations":[128],"efficiently":[129],"inhibited":[130],"human":[133],"dose-dependent":[138],"manner":[139],"regardless":[140],"their":[142],"molecular":[143],"subtypes,":[144],"broad":[147],"effect":[148],"initial":[154],"G1":[155],"arrest":[156],"induced":[157],"by":[158,166,222,243],"was":[164,175],"followed":[165],"either":[167],"apoptosis":[168],"or":[169,188],"senescence.":[170],"suppressed":[176,195],"as":[177],"result":[179],"from":[183],"natural,":[185],"chromosomally":[186],"translocated,":[187],"amplified":[189],"loci.":[190],"Furthermore,":[191],"significantly":[194],"growth":[196],"engrafted":[200,207],"mice":[202],"improved":[204],"mice.":[208],"Conclusion:":[209],"Our":[210],"results":[211],"demonstrate":[212],"BET":[217],"proteins":[221],"has":[224],"potential":[225],"clinical":[226],"use":[227],"Clin":[233],"Cancer":[234],"Res;":[235],"21(1);":[236],"113\u201322.":[237],"\u00a92014":[238],"AACR.":[239],"See":[240],"related":[241],"commentary":[242],"Mottok":[244],"Gascoyne,":[246],"p.":[247],"4":[248]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}